Patel Chem Specialities IPO Details

SME

Patel Chem Specialities IPO opens for subscription on 25 Jul 2025 and closes on 29 Jul 2025. The IPO will be listed on BSE with the tentative listing date set for 01 Aug 2025.

Patel Chem Specialities IPO price band has been fixed at ₹82 – ₹84 per share.The face value is ₹10 per share with a lot size of 1600.

Patel Chem Specialities IPO total issue size comprises 70,00,000 shares (aggregating up to ₹58.80 Cr). This includes a fresh issue of 70,00,000 shares (aggregating up to ₹58.80 Cr). Pre-issue shareholding stands at 1,78,70,000, which will increase to 2,48,70,000 post-issue.

Patel Chem Specialities IPO carries a ₹27 (32.14%) GMP, reflecting investor sentiment.

Patel Chem Specialities IPO Lot Size : Individual Minimum is 2 lots (3,200 shares) amounting to ₹268,800. Individual Maximum is 2 lots (3,200 shares) amounting to ₹268,800. SHNI Minimum is 3 lots (4,800 shares) amounting to ₹403,200. SHNI Maximum is 7 lots (11,200 shares) amounting to ₹940,800. BHNI Minimum is 8 lots (12,800 shares) amounting to ₹1,075,200.

The Lead Managers for Patel Chem Specialities IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Cumulative Capital Pvt Ltd, Unistone Capital Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Globalworth Securities Ltd. You can analyze their track record by checking the Market Maker Performance Summary report.

For detailed information, Refer to the Patel Chem Specialities Limited RHP.

Patel Chem Specialities IPO Details

Listing Price : ₹110 at a Premium of 30.95%
Open Date
25 Jul 2025
Close Date
29 Jul 2025
Listing Date
01 Aug 2025
Issue Price
₹82 - ₹84
Face Value
₹10 per share
Lot Size
1600
GMP
₹27 (32.14%)
Issue Type
IPO
Listing On
BSE
Type
Book Built Issue
Share holding pre issue
1,78,70,000 shares
Share holding post issue
2,48,70,000 shares
Total Issue Size
70,00,000 shares (aggregating up to ₹58.80 Cr)
Fresh Issue
70,00,000 shares (aggregating up to ₹58.80 Cr)
Offer for Sale
-

Patel Chem Specialities IPO Subscription

Patel Chem Specialities IPO Application Wise Breakup

Patel Chem Specialities IPO Dates

  • 25 Jul 2025
    Opening dateOpen
  • 29 Jul 2025
    Closing dateClose
  • 30 Jul 2025
    Allotment Date Allotment
  • 31 Jul 2025
    Initiation of RefundsRefund
  • 31 Jul 2025
    Credit of SharesCredit
  • 01 Aug 2025
    Listing dateListing

Patel Chem Specialities IPO Lot Size

ApplicationLotsSharesAmount
Individual Minimum23200₹268,800
Individual Maximum23200₹268,800
SHNI Minimum34800₹403,200
SHNI Maximum711200₹940,800
BHNI Minimum812800₹1,075,200

Patel Chem Specialities IPO Reservation

Promoter Holding

Pre Issue:95.13%
Post Issue:69.78%
Promoter Names:
Bhupesh Patel, Anshu Patel, Vini Patel

Patel Chem Specialities IPO Valuations

ROE:29.85%
ROCE:36.26%
DEBT/EQUITY:0.42
RONW:24.32%
PAT MARGIN:10.01%
PRICE TO BOOK VALUE:4.11
EPS Pre IPO:5.91
EPS Post IPO:4.25
P/E Pre IPO:14.21
P/E Post IPO:19.77

Patel Chem Specialities Financial Information

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets65.3146.9737.08
Revenue105.5582.7269.75
Profit After Tax10.577.662.89
EBITDA15.8012.025.83
Net Worth35.4019.5211.87
Reserves and Surplus17.5318.5210.87
Total Borrowing14.8515.4611.79
Amount in ₹ Crore

About Patel Chem Specialities IPO

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting pharmaceutical excipients and specialty chemicals.

The company manufactures various essential chemicals used in pharmaceuticals, food, cosmetics, and industrial applications, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents across industries.

The company’s manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, follow strict quality control standards, ensuring bulk production of chemicals that meet international certifications like US-DMF and GMP.

The company’s manufacturing facility covers 7,000 square yards, with a capacity of over 7,200 MT annually for pharmaceutical excipients, featuring departments for storage, production, R&D, quality control, packaging, and warehousing.

The company has expanded globally, serving East Asia, Europe, the Middle East, North America, and Southeast Asia, delivering high-quality products that meet international standards to lead the chemical industry.

Product Portfolio:
  • Rheollose® (Sodium Carboxymethyl Cellulose): A cellulose gum used as a thickening and stabilizing agent in various applications.
  • Disolwell® (Croscarmellose Sodium): A super disintegrant used in oral pharmaceutical formulations to enhance tablet disintegration.
  • Swellcal® (Calcium Carboxymethyl Cellulose): Used as a super disintegrant in pharmaceutical applications.
  • AmyloTab™ (Pregelatinized Starch): Used in tablet formulations to aid in the disintegration and dissolution processes.
As of March 31, 2025, the company has a total strength of 136 employees.

Strength Of Patel Chem Specialities IPO

1. Product Portfolio.

2. Experienced Promoter and Management group.

3. Global Presence.

4. Diversified customer base.

5. Continuous innovation and quality consistency.

Risk Of Patel Chem Specialities IPO

1. We do not have long-term agreements with our suppliers for raw materials and an inability to procure the desired quality, quantity of our raw materials in a timely manner and at reasonable costs, or at all, may have a negative impact on our business, results of operations, financial condition and cash flows.

2. Majority of our domestic purchases and imports for the last 3 Financial Years and stub period is dependent on few states and single country. Any loss of business from any of these states and country may adversely affect our ability to procure our raw materials in time to meet our customers needs.

3. Majority of our domestic sales for the last 3 Financial Years and stub period is dependent on few states. Any loss of business from any of these states may adversely affect our revenues and profitability.

4. The restated financial statements have been provided by peer reviewed auditor who is not statutory auditor of our Company.

5. Our Major Exports are to Egypt, United States, Russia, Republic of Korea, United Kingdom, Japan and Germany. Any loss of business from any of these countries may adversely affect our revenues and profitability.

6. There may be potential conflict of interests between our Company and M/s Patel Industries.

7. Our international operations expose us to complex management, legal, tax, foreign exchange and economic risks, which could adversely affect our business, results of operations and financial condition.

8. Under-utilization of our production capacities could have an adverse effect on our business, future prospects and future financial performance.

9. Risk of Potential Machinery Strain and Operational Challenges Due to Overutilization of Installed Capacity.

10. The Company is in process of obtaining Fire NOC from the Fire Safety department for plot A1/272/5 and A2/272/4, GIDC Industrial Estate, Vatva, Ahmedabad - 382445 and Survey No. 93, Talod- Himmatnagar Road, Ahmedpura, Talod, Sabarkantha 383215, Gujarat, India.

Objectives Patel Chem Specialities IPO

1. Funding capital expenditure requirement of the Company

2. General corporate purposes

Company Contact Details

Patel Chem Specialities Ltd.
Plot No. 272/4-5,
Phase II, G.I.D.C Industrial Estate,
Vatva Road
Ahmedabad, Gujarat, 382445
Phone: 91- 9712999854
Email: cs@patelchem.com
Website: http://www.patelchem.com/

Registrar Contact Details

Name: MUFG Intime India Pvt Ltd
Phone: +91-22-4918 6270

Patel Chem Specialities IPO - FAQs

The Patel Chem Specialities IPO is a SME public issue comprising 7000000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹58.80 Cr. The issue price has been fixed at ₹84 per equity share, and the minimum application size is 1600 shares.

The IPO opens for subscription on 25 Jul 2025, and closes on 29 Jul 2025.

MUFG Intime India Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the BSE

The Patel Chem Specialities IPO opens on 25 Jul 2025.

Patel Chem Specialities IPO lot size is 1600, and the minimum amount required for application is ₹134400.

You may apply for the Patel Chem Specialities IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Patel Chem Specialities IPO is scheduled to be finalized on 30 Jul 2025. Subsequently, the shares allotted will be credited to investors’ demat accounts by 31 Jul 2025. Investors are advised to regularly check the Patel Chem Specialities IPO allotment status for updates.

The listing date for the Patel Chem Specialities IPO has not yet been officially announced. However, the tentative listing date is scheduled for 01 Aug 2025.

Patel Chem Specialities IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at ₹27 (32.14%).

Comments